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Cervical cancer is a leading cause of cancer death among women in 
low- and middle-income countries.[1] In South Africa (SA), where 
the quality-improvement (QI) intervention was conducted, 1 in 
32 women develop cervical cancer in their lifetime.[2] Despite the 
existence of a national cervical screening programme, racial and 
socioeconomic inequities in cervical cancer incidence and death 
remain striking.[3,4]
When implemented effectively at scale, cervical screening 
programmes can substantially reduce the incidence of cervical cancer.[5-7] 
However, screening coverage remains low throughout SA, with only 
1 in 3 women receiving appropriate screening.[8] Furthermore, the 
quality of smears received by the National Health Laboratory Service 
(NHLS) varies. For example, the median adequacy rate – a measure 
of whether there is sufficient endocervical tissue for analysis – is 
47%, and many ‘inadequate’ smears must be repeated, resulting in 
unnecessary cost and attrition from care.[8] One explanation for the 
low adequacy rate may be the choice of sample collection device. 
Currently, the vast majority of Pap smears are obtained using a 
wooden Ayre spatula, which is associated with suboptimal sampling 
of the endocervix and a higher rate of inadequate smears compared 
with use of the cytobroom.[9,10]
We sought to improve the quality of Pap smear screening in the 
Tshwane Department of Health (DoH) facilities using two targeted 
QI activities. Specifically, our objective was to determine whether 
training with the Ayre spatula (step 1) or introduction of the cyto-
broom (step 2) resulted in greater improvements in Pap smear 
adequacy rates.
Methods
Our QI project was conducted in collaboration with the Tshwane 
DoH. Located in northern Gauteng, there are ~90 public health 
facilities that perform cervical screening in Tshwane District. We 
selected four candidate facilities, each performing at least 400 Pap 
smears per year, but with adequacy rates of <40%. Of these, two 
facilities located in urban Tshwane elected to participate.
In the pre-intervention period, between 2013 and 2014, we 
obtained aggregate-level data on the volume, adequacy rate and result 
of Pap smears performed at participating facilities. The two-step QI 
intervention was conducted between May 2016 and Febru ary 2017. 
Step 1 included 1 day of classroom training using the Ayre spatula, 
followed by 2 days of on-site mentorship. Step 2 included a 1-day 
on-site training in the use of the cytobroom. No additional mentor-
ship was provided during step 2. De-identified Pap smear data were 
obtained from the NHLS for 2 - 3 months after each step of the inter-
vention. Pap smears were reported by qualified cytotechnologists 
using the Bethesda system.[11] All smears were processed and read in 
accordance with routine laboratory procedures, and the laboratory 
staff were unaware of the intervention. 
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Background. The endocervical component of a Pap smear is an important indicator of sample quality – or ‘adequacy’. However, only 6 of 
52 districts in South Africa (SA) meet the Department of Health (DoH) performance benchmark: a 70% adequacy rate. We implemented a 
quality-improvement (QI) intervention to address suboptimal Pap smear quality in Tshwane District, Gauteng Province, SA. 
Objectives. To determine whether training with the wooden Ayre spatula (step 1) or introduction of the cytobroom (step 2) resulted in 
greater improvements in Pap smear adequacy rates.
Methods. Two Tshwane District health facilities participated in our QI project between May 2016 and February 2017. In step 1, staff received 
training on the Ayre spatula. In step 2, the spatula was replaced with the cytobroom. Pap smear volumes, adequacy rates and results are 
reported for the pre-intervention period and after each QI step. We compared adequacy rates using Fisher’s exact test, with a significance 
level of p=0.05.
Results. In the pre-intervention period, 304 of 965 Pap smears were deemed adequate (32%; 95% confidence interval (CI) 29 - 35%). After 
step 1, the proportion increased to 109 of 191 (57%; 95% CI 50 - 64%; p<0.01). Similarly, after step 2, the proportion increased to 155 of 
192 (81%; 95% CI 74 - 86%; p<0.01). The proportion of abnormal smears increased from 13% before the QI intervention to 17% after step 
1 and 22% after step 2.
Conclusion. Although training in Pap smear collection using the Ayre spatula resulted in modest improvements in quality, facilities only 
achieved the DoH benchmark of a 70% adequacy rate after the introduction of the cytobroom.
S Afr Med J 2018;108(11):926-928. DOI:10.7196/SAMJ.2018.v108i11.13153
927       November 2018, Vol. 108, No. 11
RESEARCH
In this article, we describe Pap smear volumes and adequacy 
rates (proportion of samples with a representative endocervical 
component) for the pre-intervention period, as well as after each 
QI step. We also report the proportion, including 95% confidence 
intervals (CIs), of abnormal Pap smears, defined as atypical squamous 
cells of undetermined significance or worse (ASCUS+), as this is the 
colposcopy referral threshold recommended by the DoH and World 
Health Organization (WHO).[3,12] Hypothesis testing was performed 
using Fisher’s exact tests, at a significance level of p=0.05.
Ethical approval
Ethical approval was granted by the University of the Witwatersrand 
Human Research Ethics Committee (ref. no. M150971) and the 
Tshwane Research Committee (ref. no. 07/2016). 
Results
In the pre-intervention period (2013 - 2014), results were reported 
for 960 of 965 Pap smears performed at participating facilities. 
After step 1, which consisted of training and mentorship on the 
Ayre spatula, results were reported for 204 of 210 Pap smears. After 
step 2, during which the cytobroom was introduced, results were 
reported for 212 of 219 Pap smears. Because of laboratory error, 
some results were missing. The Pap smear adequacy rate during the 
pre-intervention period was 32% (95% CI 29 - 35%) (Fig. 1). After 
step 1, the adequacy rate increased to 57% (95% CI 50 - 64%; p<0.01). 
Similarly, after step 2, we observed further improvement in the Pap smear 
adequacy rate to 81% (95% CI 74 - 86%; p<0.01). Results were similar 
when the analysis was performed disaggregated by clinic (data not shown). 
With improvements in Pap smear adequacy rates throughout the 
QI project, we also observed increases in Pap smear abnormalities 
(Table 1). In the pre-intervention period, the proportion of abnormal 
results (ASCUS+) was 13% (95% CI 11 - 15%). After step 1, these 
rose to 17% (95% CI 12 - 23%), while after step 2, 22% were read as 
ASCUS+ (95% CI 17 - 28%). 
Discussion 
Although Pap smear quality is not determined solely by the 
presence of an endocervical component, we focused our QI project 
on Pap smear adequacy, as many public health facilities in SA 
consistently fall below the DoH benchmark for this metric. Our 
findings illustrate how simple QI interventions can improve Pap 
smear adequacy rates in public-sector health facilities. We found 
that both training on the Ayre spatula and introduction of the 
cytobroom resulted in statistically significant improvements in 
adequacy rates. We observed a 25% increase (from 32% to 57%) in 
Pap smear adequacy after training and a further 24% rise after the 
introduction of the cytobroom (from 57% to  81%).
We are not aware of any prior studies comparing training with 
the introduction of the cytobroom to improve Pap smear adequacy 
rates in SA. Our findings are consistent with those in the existing 
literature on Pap smear collection devices, demonstrating higher 
adequacy rates when Pap smears are performed using a cytobroom 
compared with a wooden spatula (odds ratio 1.6; 95% CI 1.4 - 
1.7%).[9,10] A recent cost-effectiveness analysis indicated that using 
the cytobroom for Pap smear collection would save SA’s public 
health system USD0.67 million per year.[13] The modelling analysis 
also estimated that introducing the cytobroom would result in a 
28% reduction in the number of women receiving false-negative 
diagnoses owing to increased identification of high-grade intra-
epithelial lesions.[13]
Study limitations
We noted several limitations of the project: (i) the number of 
participating clinics was small and both clinics were located in urban 
Gauteng, limiting the generalisability of our findings; (ii) we did not 
collect detailed clinic- or patient-level data and were unable to assess 
selection bias or examine other factors that may have influenced our 
findings; (iii) we did not consider other aspects of smear quality or 
address broader issues of access or coverage of cervical screening; 
and (iv) there may have been some variability in interpretation by 
different cytotechnologists. While these points may have introduced 
random error, they were not anticipated to have led to bias in our 
results in any systematic way. Future evaluations should be conducted 
with a larger, more representative sample of clinics and should assess 
patient-level factors on Pap smear adequacy rates. 
Conclusion
Training and mentorship in the use of the Ayre spatula can significantly 
improve Pap smear adequacy rates. However, use of the cytobroom 
for Pap smear collection is the most efficient way to improve 
sample adequacy and DoH clinics should consider introducing the 
cytobroom as the standard collection device for Pap smears.
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Table 1. Pap smear results before intervention and after each step of the quality-improvement intervention
Pre-intervention Post step 1 Post step 2
n % (95% CI) n % (95% CI) n % (95% CI)
NILM 838 87 (85 - 89) 170 83 (77 - 88) 165 78 (72 - 83)
ASCUS+ 122 13 (11 - 15) 34 17 (12 - 23) 47 22 (17 - 28)
Total 960 100 204 100 212 100
CI = confidence interval; NILM = no intra-epithelial lesion or malignancy; ASCUS+ = atypical squamous cells of undetermined significance or worse.
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Fig. 1. Pap smear adequacy rates pre-intervention and after each step of the 
quality-improvement intervention.
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